ICOC Committed funds:
Awards as PI
|Tissue Collection for Disease Modeling||Tissue Collection for Accelerating iPSC Research in Cardiovascular Diseases||$1,435,371|
|SEED Grant||In Vivo Imaging of Human Embryonic Stem Cell Derivatives and Tumorigenicity||$658,123|
|Disease Team Therapy Development - Research||Human Embryonic Stem Cell-Derived Cardiomyocytes for Patients with End Stage Heart Failure||$19,999,899|
|Early Translational III||Heart Repair with Human Tissue Engineered Myocardium||$4,766,231|
Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.
In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation.
Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain.
Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction.
Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury.